Breaking News Instant updates and real-time market news.

CYDY

CytoDyn

$1.89 /

+0.09 (+5.00%)

08:54
06/21/21
06/21
08:54
06/21/21
08:54

CytoDyn announces preliminary results of data from long-haulers trial

CytoDyn announced preliminary results after unblinding the data from its COVID-19 long-haulers clinical trial The purpose of this clinical trial was to assess the safety and efficacy of leronlimab administered as weekly subcutaneous injection in subjects experiencing prolonged symptoms of COVID-19. The primary outcome was change from baseline in daily COVID-19-related symptom severity score through Day 56. Secondary outcomes included progression of COVID-19-associated symptoms through Day 56 compared to baseline. Patient symptoms were self-reported daily throughout the 56-day evaluation period and reported electronically. The symptom scores were rated as severe, moderate, mild, and none. Chris Recknor, M.D., CytoDyn's Chief Operating Officer and Head of Clinical Development, commented, "We are very pleased with the preliminary results from our long-haulers trial, which showed a greater improvement in the leronlimab patient group over placebo in 18 of 24 COVID-19 symptoms. Although the study was not designed to show statistically significant differences due to the small sample size of 56 patients, clinically meaningful improvements in leronlimab over placebo were observed for cough, stuffy/runny nose, shortness of breath, tightness of chest, feeling of fast heartbeat, fatigue, muscle aches/cramps, muscle weakness, joint pain/swelling, chills/shivering, feeling hot or feverish, difficulty in concentration, sleep disturbance/insomnia, headache, dizziness, tingling/numbness, sense of taste, and sense of smell. Of the remaining 6 symptoms, sore throat, exertional malaise, anxiety, nausea, and vomiting had no clinically meaningful change. Diarrhea was worse in leronlimab treated compared to placebo. Biomarkers at multiple timepoints are being analyzed to help determine reasons for response and to provide better insight into the mechanism of action of leronlimab. As in other previous trials with leronlimab, no adverse safety signals were noted. Once our final analysis is performed, we will seek to hold discussions with the FDA regarding next steps."

  • 21

    Jun

CYDY CytoDyn
$1.89 /

+0.09 (+5.00%)

04/06/21
CytoDyn to host conference call
07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
HBO Max offering access to select free episodes » 18:35
08/03/21
08/03
18:35
08/03/21
18:35
T

AT&T

$28.20 /

+0.1 (+0.36%)

, SNAP

Snap

$73.38 /

-0.125 (-0.17%)

WarnerMedia (T) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
T AT&T
$28.20 /

+0.1 (+0.36%)

SNAP Snap
$73.38 /

-0.125 (-0.17%)

T AT&T
$28.20 /

+0.1 (+0.36%)

07/27/21
Fly Intel: Top five analyst downgrades
07/27/21 Argus
AT&T cut to Hold at Argus on potential dividend cut
07/27/21 Argus
AT&T downgraded to Hold from Buy at Argus
07/26/21 Deutsche Bank
AT&T price target raised to $37 from $34 at Deutsche Bank
SNAP Snap
$73.38 /

-0.125 (-0.17%)

07/29/21 Wells Fargo
Facebook price target raised to $450 from $415 at Wells Fargo
07/27/21 Citi
Snap price target raised to $67 from $42 at Citi
07/23/21 Jefferies
Snap price target raised to $90 from $81 at Jefferies
07/23/21 Cowen
Snap price target raised to $96 from $90 at Cowen
T AT&T
$28.20 /

+0.1 (+0.36%)

SNAP Snap
$73.38 /

-0.125 (-0.17%)

T AT&T
$28.20 /

+0.1 (+0.36%)

SNAP Snap
$73.38 /

-0.125 (-0.17%)

T AT&T
$28.20 /

+0.1 (+0.36%)

SNAP Snap
$73.38 /

-0.125 (-0.17%)

T AT&T
$28.20 /

+0.1 (+0.36%)

SNAP Snap
$73.38 /

-0.125 (-0.17%)

Hot Stocks
Gol Linhas signs agreements for 28 additional Boeing 737 MAX-8 aircraft » 18:35
08/03/21
08/03
18:35
08/03/21
18:35
GOL

Gol Linhas

$7.74 /

-0.1 (-1.28%)

, BA

Boeing

$229.10 /

+3.81 (+1.69%)

Gol Linhas (GOL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOL Gol Linhas
$7.74 /

-0.1 (-1.28%)

BA Boeing
$229.10 /

+3.81 (+1.69%)

GOL Gol Linhas
$7.74 /

-0.1 (-1.28%)

06/14/21 HSBC
Gol Linhas price target raised to R$26 from R$25 at HSBC
05/05/21 HSBC
Gol Linhas downgraded to Hold from Buy at HSBC
04/11/21 Goldman Sachs
Gol Linhas price target lowered to $9.85 from $11.05 at Goldman Sachs
04/01/21 Itau BBA
Gol Linhas initiated with a Market Perform at Itau BBA
BA Boeing
$229.10 /

+3.81 (+1.69%)

07/30/21 BofA
Albany International upgraded to Buy from Neutral at BofA
07/29/21 Susquehanna
Boeing estimates raised following earnings beat at Susquehanna
07/14/21 Morgan Stanley
Boeing's 787 'minor headache' doesn't change thesis, says Morgan Stanley
07/13/21
Fly Intel: Top five analyst upgrades
GOL Gol Linhas
$7.74 /

-0.1 (-1.28%)

BA Boeing
$229.10 /

+3.81 (+1.69%)

BA Boeing
$229.10 /

+3.81 (+1.69%)

GOL Gol Linhas
$7.74 /

-0.1 (-1.28%)

BA Boeing
$229.10 /

+3.81 (+1.69%)

BA Boeing
$229.10 /

+3.81 (+1.69%)

Hot Stocks
Farallon Capital reports 5.9% passive stake in Caribou Biosciences » 18:33
08/03/21
08/03
18:33
08/03/21
18:33
CRBU

Caribou Biosciences

$17.27 /

-0.23 (-1.31%)

Farallon Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 23
    Jul
CRBU Caribou Biosciences
$17.27 /

-0.23 (-1.31%)

Periodicals
Blizzard tells Verge HR boss Meschuk no longer with company » 18:25
08/03/21
08/03
18:25
08/03/21
18:25
ATVI

Activision Blizzard

$79.85 /

-2.91 (-3.52%)

Following the departure…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

08/02/21 Credit Suisse
Activision Blizzard price target raised to $125 from $120 at Credit Suisse
07/21/21 Deutsche Bank
Deutsche names Electronic Arts top pick in video games, upgrades to Buy
07/21/21 Deutsche Bank
Activision Blizzard price target lowered to $115 from $118 at Deutsche Bank
07/13/21 Berenberg
Activision Blizzard price target raised to $110 from $105 at Berenberg
ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

ATVI Activision Blizzard
$79.85 /

-2.91 (-3.52%)

Hot Stocks
Melody submits proposal to purchase all assets from Landmark Infrastructure » 18:24
08/03/21
08/03
18:24
08/03/21
18:24
LMRK

Landmark Infrastructure

$13.09 /

+0.04 (+0.31%)

Melody Investment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMRK Landmark Infrastructure
$13.09 /

+0.04 (+0.31%)

LMRK Landmark Infrastructure
$13.09 /

+0.04 (+0.31%)

05/21/21 Wells Fargo
Landmark Infrastructure upgraded to Equal Weight from Underweight at Wells Fargo
05/17/21 B. Riley
Landmark Infrastructure downgraded to Neutral from Buy at B. Riley
04/22/21 Raymond James
Raymond James starts Radius Global Infrastructure at Outperform on pricing power
02/25/21 B. Riley Securities
Landmark Infrastructure price target raised to $16 from $15 at B. Riley Securities
LMRK Landmark Infrastructure
$13.09 /

+0.04 (+0.31%)

Hot Stocks
NextDecade comments on U.S. Court of Appeals order » 18:22
08/03/21
08/03
18:22
08/03/21
18:22
NEXT

NextDecade

$3.05 /

-0.25 (-7.58%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEXT NextDecade
$3.05 /

-0.25 (-7.58%)

NEXT NextDecade
$3.05 /

-0.25 (-7.58%)

06/08/21 Evercore ISI
NextDecade upgraded to Outperform from In Line at Evercore ISI
06/07/21 Morgan Stanley
Morgan Stanley upgraded Tellurian to Equal Weight, quadruples price target to $8
06/07/21 Morgan Stanley
Morgan Stanley upgrades NextDecade to Overweight, triples price target to $6
06/07/21 Morgan Stanley
NextDecade upgraded to Overweight from Equal Weight at Morgan Stanley
NEXT NextDecade
$3.05 /

-0.25 (-7.58%)

NEXT NextDecade
$3.05 /

-0.25 (-7.58%)

Hot Stocks
Innovative Industrial Properties acquires Illinois property for $6.5M » 18:07
08/03/21
08/03
18:07
08/03/21
18:07
IIPR

Innovative Industrial Properties

$213.71 /

-0.29 (-0.14%)

Innovative Industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IIPR Innovative Industrial Properties
$213.71 /

-0.29 (-0.14%)

IIPR Innovative Industrial Properties
$213.71 /

-0.29 (-0.14%)

07/02/21 Wolfe Research
Innovative Industrial Properties initiated with an Outperform at Wolfe Research
06/28/21 Ladenburg
Innovative Industrial Properties' environment 'largely stable,' says Ladenburg
01/29/21 JMP Securities
Innovative Industrial Properties price target raised to $225 from $185 at JMP
01/07/21 BTIG
Innovative Industrial Properties price target raised to $218 from $177 at BTIG
IIPR Innovative Industrial Properties
$213.71 /

-0.29 (-0.14%)

IIPR Innovative Industrial Properties
$213.71 /

-0.29 (-0.14%)

Earnings
Community Healthcare reports Q2 AFFO 56c, consensus 55c » 18:06
08/03/21
08/03
18:06
08/03/21
18:06
CHCT

Community Healthcare

$49.83 /

+0.73 (+1.49%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHCT Community Healthcare
$49.83 /

+0.73 (+1.49%)

CHCT Community Healthcare
$49.83 /

+0.73 (+1.49%)

06/15/21 B. Riley
Community Healthcare price target raised to $52 from $50 at B. Riley
11/27/20 Truist
Community Healthcare price target raised to $50 from $49 at Truist
11/25/20 Evercore ISI
Community Healthcare upgraded to Outperform from In Line at Evercore ISI
11/05/20 B. Riley Securities
Community Healthcare price target raised to $49 from $47 at B. Riley Securities
CHCT Community Healthcare
$49.83 /

+0.73 (+1.49%)

Earnings
Mayville Engineering raises FY21 revenue view to $470M-$490M from $450M-$470M » 18:04
08/03/21
08/03
18:04
08/03/21
18:04
MEC

Mayville Engineering

$17.53 /

+0.24 (+1.39%)

FY21 consensus $462.93M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

06/25/21 Citi
Citi has 'increased conviction' in Mayville after management meetings
04/08/21 Baird
Mayville Engineering strategic customer adds to growth potential, says Baird
03/03/21 Baird
Mayville Engineering results suggest volume recovery continues, says Baird
02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

Earnings
Douglas Emmett reports Q2 adjusted FFO 47c, consensus 44c » 18:03
08/03/21
08/03
18:03
08/03/21
18:03
DEI

Douglas Emmett

$32.32 /

-0.545 (-1.66%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DEI Douglas Emmett
$32.32 /

-0.545 (-1.66%)

DEI Douglas Emmett
$32.32 /

-0.545 (-1.66%)

06/03/21 Mizuho
Douglas Emmett upgraded to Buy from Neutral at Mizuho
04/14/21 Mizuho
Douglas Emmett price target raised to $32 from $28 at Mizuho
01/12/21 Raymond James
Douglas Emmett downgraded to Market Perform from Outperform at Raymond James
01/12/21 Raymond James
Douglas Emmett downgraded to Market Perform from Outperform at Raymond James
DEI Douglas Emmett
$32.32 /

-0.545 (-1.66%)

Earnings
Mayville Engineering reports Q2 EPS 16c, consensus 19c » 18:03
08/03/21
08/03
18:03
08/03/21
18:03
MEC

Mayville Engineering

$17.53 /

+0.24 (+1.39%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

06/25/21 Citi
Citi has 'increased conviction' in Mayville after management meetings
04/08/21 Baird
Mayville Engineering strategic customer adds to growth potential, says Baird
03/03/21 Baird
Mayville Engineering results suggest volume recovery continues, says Baird
02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
MEC Mayville Engineering
$17.53 /

+0.24 (+1.39%)

Earnings
Aquestive Therapeutics raises FY21 revenue view to $46M-$48M from $38M-$42M » 17:58
08/03/21
08/03
17:58
08/03/21
17:58
AQST

Aquestive Therapeutics

$3.26 /

-0.045 (-1.36%)

FY21 consensus $40.07M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
09/28/20 Lake Street
Aquestive Therapeutics price target lowered to $7 from $10 at Lake Street
09/28/20 RBC Capital
Aquestive Therapeutics price target lowered to $7 from $8 at RBC Capital
AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

Earnings
Aquestive Therapeutics reports Q2 EPS (33c), consensus (44c) » 17:57
08/03/21
08/03
17:57
08/03/21
17:57
AQST

Aquestive Therapeutics

$3.26 /

-0.045 (-1.36%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
09/28/20 Lake Street
Aquestive Therapeutics price target lowered to $7 from $10 at Lake Street
09/28/20 RBC Capital
Aquestive Therapeutics price target lowered to $7 from $8 at RBC Capital
AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

AQST Aquestive Therapeutics
$3.26 /

-0.045 (-1.36%)

Initiation
Just Eat Takeaway reinstated with a Buy at Goldman Sachs » 17:53
08/03/21
08/03
17:53
08/03/21
17:53
GRUB

Just Eat Takeaway

$17.72 /

-0.29 (-1.61%)

Goldman Sachs analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRUB Just Eat Takeaway
$17.72 /

-0.29 (-1.61%)

GRUB Just Eat Takeaway
$17.72 /

-0.29 (-1.61%)

07/26/21 JPMorgan
Just Eat Takeaway price target raised to 9,145 GBp from 8,915 GBp at JPMorgan
07/16/21 JPMorgan
Just Eat Takeaway price target lowered to 8,915 GBp from 9,053 GBp at JPMorgan
07/13/21 Morgan Stanley
Just Eat Takeaway price target lowered to 11,100 GBp at Morgan Stanley
07/13/21 Deutsche Bank
Just Eat Takeaway price target lowered to EUR 100 from EUR 116 at Deutsche Bank
GRUB Just Eat Takeaway
$17.72 /

-0.29 (-1.61%)

GRUB Just Eat Takeaway
$17.72 /

-0.29 (-1.61%)

GRUB Just Eat Takeaway
$17.72 /

-0.29 (-1.61%)

Initiation
Delivery Hero reinstated with a Buy at Goldman Sachs » 17:51
08/03/21
08/03
17:51
08/03/21
17:51
DLVHF

Delivery Hero

$153.00 /

-0.3 (-0.20%)

Goldman Sachs analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLVHF Delivery Hero
$153.00 /

-0.3 (-0.20%)

DLVHF Delivery Hero
$153.00 /

-0.3 (-0.20%)

07/26/21 JPMorgan
Delivery Hero price target raised to EUR 212 from EUR 189 at JPMorgan
07/13/21 Deutsche Bank
Delivery Hero price target raised to EUR 150 from EUR 135 at Deutsche Bank
07/07/21 Bernstein
Delivery Hero initiated with an Outperform at Bernstein
07/02/21 JPMorgan
Delivery Hero price target raised to EUR 189 from EUR 185 at JPMorgan
Earnings
Primoris sees FY21 EPS $2.30-$2.50, consensus $2.46 » 17:46
08/03/21
08/03
17:46
08/03/21
17:46
PRIM

Primoris

$30.24 /

+0.56 (+1.89%)

Balancing the ongoing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRIM Primoris
$30.24 /

+0.56 (+1.89%)

PRIM Primoris
$30.24 /

+0.56 (+1.89%)

07/16/21
Fly Intel: Top five analyst initiations
07/16/21 UBS
Primoris initiated with a Buy at UBS
07/15/21 Morgan Stanley
Primoris initiated with an Overweight at Morgan Stanley
06/15/21 Goldman Sachs
Primoris initiated with a Neutral at Goldman Sachs
PRIM Primoris
$30.24 /

+0.56 (+1.89%)

  • 18
    Mar
Earnings
Primoris reports Q2 EPS 67c, consensus 74c » 17:46
08/03/21
08/03
17:46
08/03/21
17:46
PRIM

Primoris

$30.24 /

+0.56 (+1.89%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRIM Primoris
$30.24 /

+0.56 (+1.89%)

PRIM Primoris
$30.24 /

+0.56 (+1.89%)

07/16/21
Fly Intel: Top five analyst initiations
07/16/21 UBS
Primoris initiated with a Buy at UBS
07/15/21 Morgan Stanley
Primoris initiated with an Overweight at Morgan Stanley
06/15/21 Goldman Sachs
Primoris initiated with a Neutral at Goldman Sachs
PRIM Primoris
$30.24 /

+0.56 (+1.89%)

  • 18
    Mar
Syndicate
Ingersoll-Rand 29.79M share Spot Secondary; price range $49.25-$49.50 » 17:42
08/03/21
08/03
17:42
08/03/21
17:42
IR

Ingersoll-Rand

$49.62 /

+1.27 (+2.63%)

JPMorgan is acting as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$49.62 /

+1.27 (+2.63%)

IR Ingersoll-Rand
$49.62 /

+1.27 (+2.63%)

07/19/21 Wolfe Research
Ingersoll-Rand, SPX Flow deal report 'credible,' says Wolfe Research
07/12/21 Wolfe Research
Ingersoll-Rand upgraded to Outperform with $61 target at Wolfe Research
07/12/21 Wolfe Research
Ingersoll-Rand upgraded to Outperform from Peer Perform at Wolfe Research
07/06/21
Fly Intel: Top five analyst upgrades
IR Ingersoll-Rand
$49.62 /

+1.27 (+2.63%)

  • 11
    May
IR Ingersoll-Rand
$49.62 /

+1.27 (+2.63%)

IR Ingersoll-Rand
$49.62 /

+1.27 (+2.63%)

Conference/Events
ON Semiconductor to hold a virtual meeting » 17:41
08/03/21
08/03
17:41
08/03/21
17:41
ON

ON Semiconductor

$45.39 /

+1.76 (+4.03%)

Virtual Strategic Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ON ON Semiconductor
$45.39 /

+1.76 (+4.03%)

ON ON Semiconductor
$45.39 /

+1.76 (+4.03%)

09:36 Today Truist
ON Semiconductor price target raised to $51 from $46 at Truist
08:53 Today Benchmark
ON Semiconductor transferred with a Buy at Benchmark
08:44 Today Craig-Hallum
ON Semiconductor price target raised to $52 from $45 at Craig-Hallum
08:42 Today BMO Capital
ON Semiconductor price target raised to $45 from $40 at BMO Capital
ON ON Semiconductor
$45.39 /

+1.76 (+4.03%)

ON ON Semiconductor
$45.39 /

+1.76 (+4.03%)

ON ON Semiconductor
$45.39 /

+1.76 (+4.03%)

Syndicate
ZoomInfo 20M share Spot Secondary; price range $55.25-$56.00 » 17:41
08/03/21
08/03
17:41
08/03/21
17:41
ZI

ZoomInfo

$56.52 /

+1.765 (+3.22%)

Morgan Stanley is acting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZI ZoomInfo
$56.52 /

+1.765 (+3.22%)

ZI ZoomInfo
$56.52 /

+1.765 (+3.22%)

09:54 Today
Fly Intel: Top five analyst initiations
09:32 Today Truist
ZoomInfo price target raised to $80 from $70 at Truist
08:28 Today Wells Fargo
ZoomInfo price target raised to $76 from $64 at Wells Fargo
08:16 Today Canaccord
ZoomInfo price target raised to $70 from $65 at Canaccord
ZI ZoomInfo
$56.52 /

+1.765 (+3.22%)

  • 04
    Aug
  • 02
    Dec
  • 20
    Aug
ZI ZoomInfo
$56.52 /

+1.765 (+3.22%)

Earnings
Microchip sees Q2 non-GAAP EPS $2.05-$2.17, consensus $1.99 » 17:35
08/03/21
08/03
17:35
08/03/21
17:35
MCHP

Microchip

$146.91 /

+1.88 (+1.30%)

Sees Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

08/02/21 Morgan Stanley
Microchip transferred with an Overweight at Morgan Stanley
07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Mizuho
Microchip downgraded to Neutral from Buy at Mizuho
07/06/21 KeyBanc
Microchip price target raised to $185 from $180 at KeyBanc
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

Earnings
Microchip reports Q1 adjusted EPS $1.98, consensus $1.91 » 17:33
08/03/21
08/03
17:33
08/03/21
17:33
MCHP

Microchip

$146.91 /

+1.88 (+1.30%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

08/02/21 Morgan Stanley
Microchip transferred with an Overweight at Morgan Stanley
07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Mizuho
Microchip downgraded to Neutral from Buy at Mizuho
07/06/21 KeyBanc
Microchip price target raised to $185 from $180 at KeyBanc
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

Hot Stocks
Microchip raises quarterly dividend 5.8% to 43.7c per share » 17:32
08/03/21
08/03
17:32
08/03/21
17:32
MCHP

Microchip

$146.91 /

+1.88 (+1.30%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

08/02/21 Morgan Stanley
Microchip transferred with an Overweight at Morgan Stanley
07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Mizuho
Microchip downgraded to Neutral from Buy at Mizuho
07/06/21 KeyBanc
Microchip price target raised to $185 from $180 at KeyBanc
MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

MCHP Microchip
$146.91 /

+1.88 (+1.30%)

Hot Stocks
Talos Energy backs FY21 capex view of $340M-$370M » 17:30
08/03/21
08/03
17:30
08/03/21
17:30
TALO

Talos Energy

$11.36 /

+0.12 (+1.07%)

Backs FY21 total output…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

  • 24
    Jun
  • 09
    Dec
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

Earnings
Talos Energy reports Q2 EPS (1c), consensus (15c) » 17:28
08/03/21
08/03
17:28
08/03/21
17:28
TALO

Talos Energy

$11.36 /

+0.12 (+1.07%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

  • 24
    Jun
  • 09
    Dec
TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

TALO Talos Energy
$11.36 /

+0.12 (+1.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.